Global Immunohematology Industry Trends and Growth Forecast for 2026–2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Immunohematology Market By 2030 Starting From Its 2026 Size?

The immunohematology market size has observed consistent expansion over recent years. It is projected to expand from $2.56 billion in 2025 to $2.69 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. The market’s growth in previous periods can be attributed to the increasing prevalence of blood disorders, a rising demand for safe blood transfusions, the development of blood banks, the growth in diagnostic laboratories, and advancements in hematology reagents.

The immunohematology market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a value of $3.27 billion, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast period is attributable to several factors, including ongoing technological progress in analyzers, the increasing adoption of artificial intelligence in laboratory diagnostics, the growing prominence of precision medicine, the incorporation of digital health systems, and the broadening reach of blood screening initiatives. Key trends expected within the forecast timeframe encompass sophisticated blood typing methods, enhanced automation in immunohematology tests, individualized transfusion treatment, on-site immune diagnostic tools, and the seamless integration of laboratory information systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Immunohematology Market?

The expanding elderly demographic is set to fuel the expansion of the immunohematology market moving forward. An aging population is defined as a demographic scenario where the proportion of older individuals within a society or population increases. Immunohematology plays a vital role in addressing transfusion requirements linked to age, guaranteeing the safe application of blood products, and supporting medical procedures for the elderly. For example, as reported in January 2024 by the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, this age group’s percentage of the total population is expected to climb from 17% to 23% during the same timeframe. Consequently, the aging population is a significant factor driving the growth of the immunohematology market.

Which Segment Categories Define The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Major Market Trends Are Driving Changes In The Immunohematology Market?

Major companies in the immunohematology market are concentrating on developing advanced diagnostic methods, such as soluble recombinant proteins, designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is a protein created using recombinant DNA technology that remains correctly folded and functional in a soluble form within a host cell or solution, thus facilitating its application in research and therapeutic contexts. For example, in November 2023, Grifols, S.A., a Spanish pharmaceutical company, introduced its Grifols sCD38 solution. Grifols sCD38 is the first-ever soluble recombinant protein developed to address the interference from the cancer therapy daratumumab in vital blood transfusion compatibility testing. Specifically formulated for multiple myeloma patients, this innovative solution prevents daratumumab from attaching to CD38 proteins on red blood cells, thereby ensuring precise pre-transfusion test results. By streamlining the processes for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in delivering essential transfusions.

Who Are The Top Companies Competing In The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Read the full immunohematology market report here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Regions Are Projected To Dominate The Immunohematology Market In The Coming Years?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunohematology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795